The evidence for its health benefits is mixed a
Heres where things get really serious: Chronic, high-dose use of any IGF-1 analog carries theoretical risk of organ growth (visceral tissue, heart, intestines) and potential contribution to tumor growth in individuals with existing but undiagnosed cancers
This medication mimics the gut hormone, GLP-1, which is released after eating, slowing down your digestion and the movement of food in your gut so you stay full for a longer amount of time
All the other companies (Viking Therapeutics, Structure Therapeutics, Altimmune, etc.) have either just completed Phase 2 or are still in Phase 2, which means any results will take years to materialize
Do launder pillowcases and sheets often
Many individuals begin noticing appetite suppression within the first few weeks, while more noticeable weight loss often develops over the following months